FDA recall, , Moderate risk
American Health Packaging Meclizine Hydrochloride Tablets
Meclizine Hydrochloride Tablets failed tablet specifications.
Summary by Recall Canary from the FDA notice
What happened
Amerisource Health Services LLC, of Columbus, Ohio, recalled Meclizine Hydrochloride Tablets, USP 12.5 mg, because the tablets failed tablet specifications. The recall, which began March 16, 2026, covers 697 cartons distributed nationwide in the U.S. The product was distributed by American Health Packaging, Columbus, Ohio, 43217.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Meclizine Hydrochloride Tablets, USP 12.5 mg
- NDC
- 60687-775-65
- 60687-775-11
- Lot code
- 1024852
Recall details
- Company began the recall
- Sold in
U.S. Nationwide
- Company
- Amerisource Health Services LLCColumbus, Ohio
- Hazard
- Quality testing problem
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98526
- Recall number
- D-0418-2026
- Quantity recalled
- 697 cartons
All recalls from Amerisource Health Services LLC
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
